Résultats de la recherche - 43 results
EBoD-FL. Guidelines for mapping the environmental burden of disease in Flanders
Flanders, an effort to routinely quantify the environmental disease burden completely and coherently has thus far not been established. For this reason, Sciensano and Agentschap Zorg & Gezondheid are ...
Annual Report Belgian Cystic Fibrosis Registry 2018
del heterozygous. The main reasons for diagnosis of CF are acute or recurrent respiratory problems (41.9%) and failure to thrive (24.9%). About 19.2% were diagnosed via neonatal screening even though ...
Annual Report Belgian Cystic Fibrosis Registry 2017
18 years ago, 39.0% were adults, and the median age was 14.9 years. 46.4% of the patients are homozygous for the F508 del mutation and 39.1% are F508 del heterozygous. The main reasons for diagnosis of ...
Point Prevalence Study of Healthcare-Associated Infections and Antimicrobial Use in Belgian Acute-Care Hospitals: Results of the ECDC PPS 2017
a beta-lactamase inhibitor (J01CR05, 7.7%). The most frequently reported diagnoses for medical antimicrobial treatment were pneumonia (22.2%) and urinary tract infections (11.2%). The reason for antimicrobial use ...
Annual report Belgian Cystic Fibrosis Registry 2016
heterozygous. The main reasons for diagnosis of CF are acute or recurrent respiratory problems (42.1%) and failure to thrive (24.4%). About 18.0% were diagnosed via neonatal screening even though Belgium has no ...
National Surveillance of Infections acquired in Intensive Care Units: Annual Report 2015
ICU-acquired Bloodstream infections per 1000 patient days (Ref 5). The low participation to the NSIH- ICU surveillance in the last couple of years needs extra attention. The reasons for this are multiple. First, ...
Characterization of suspected illegal skin whitening cosmetics.
may provoke as well local as systemic toxic effects, being the reason for their banning from the EU market. In that respect, illegal and restricted substances in cosmetics, known to have bleaching ...
Patterns and trends in human papillomavirus-related diseases in Central and Eastern Europe and Central Asia.
Armenia, Azerbaijan, Ukraine, the Russian Federation and Kazakhstan. In several countries with longstanding cancer registries of reasonable quality (Belarus, Estonia and the Russian Federation), there are ...
Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.
screening registry are major reasons for low success rates of cervical cancer programs in many of the countries. Finally, HPV vaccination is currently not widely implemented in most of the twelve countries ...
Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Central and Eastern Europe.
programme and currently provide routine vaccination free of charge to the primary target population. The key reasons for lack of implementation of HPV vaccination into the national immunization programme are ...